The contribution of P-glycoprotein to clinical pharmacokinetic interactions between lenalidomide and temsirolimus

被引：0
|
作者：
Yang, Xiaoxia [1 ]
Craig, Hofmeister C. [1 ]
Rozewski, Darlene M. [1 ]
Lee, Seungsoo [1 ]
Chen, Ping [1 ]
Johnson, Amy J. [1 ]
Liu, Zhongfa [1 ]
Hade, Erinn M. [1 ]
Ji, Jia [1 ]
Schaaf, Larry J. [1 ]
Benson, Don M. [1 ]
Kraut, Eric H. [1 ]
Hicks, William J. [1 ]
Chan, Kenneth K. [1 ]
Chen, Ching-Shih [1 ]
Farag, Sherif S. [2 ]
Grever, Michael R. [1 ]
Byrd, John C. [1 ]
Phelps, Mitch A. [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-5473
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5473
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions
    Yu, DK
    JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (12): : 1203 - 1211
  • [2] Phase I Study Of P-Glycoprotein (P-gp) Mediated Drug Interactions Between Lenalidomide (LEN) and Quinidine Or Temsirolimus
    Chen, Nianhang
    Weiss, Daniel
    Reyes, Josephine
    Liu, Liangang
    Kasserra, Claudia
    Wang, Xiaomin
    Zhou, Simon
    Kumar, Gondi
    Weiss, Lilia
    Palmisano, Maria
    BLOOD, 2013, 122 (21)
  • [3] Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein
    Cho, Hyun-Jong
    Yoon, In-Soo
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [4] Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats
    K. Kishore Kumar
    Leena Priyanka
    K. Gnananath
    P. Ravindra Babu
    S. Sujatha
    European Journal of Drug Metabolism and Pharmacokinetics, 2015, 40 : 267 - 276
  • [5] Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats
    Kumar, K. Kishore
    Priyanka, Leena
    Gnananath, K.
    Babu, P. Ravindra
    Sujatha, S.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2015, 40 (03) : 267 - 276
  • [6] CLINICAL SIGNIFICANT P-GLYCOPROTEIN DRUG INTERACTIONS?
    Lee, Caroline A.
    Fenner, Katherine S.
    Kempshall, Sarah
    Cook, Jack
    Ware, Joseph Alan
    Troutman, Matthew D.
    DRUG METABOLISM REVIEWS, 2008, 40 : 208 - 208
  • [7] Interactions between artemisinin derivatives and P-glycoprotein
    Wang, Yulin
    Li, Yongjie
    Shang, Dong
    Efferth, Thomas
    PHYTOMEDICINE, 2019, 60
  • [8] In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects
    Shoaf, Susan E.
    Ohzone, Yoshihiro
    Ninomiya, Shin-ichi
    Furukawa, Masayuki
    Bricmont, Patricia
    Kashiyama, Eiji
    Mallikaarjun, Suresh
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05): : 761 - 769
  • [9] Pharmacokinetic interaction between digoxin and rifampin - The role of P-glycoprotein
    Greiner, B
    von Richter, O
    Fritz, P
    Zundler, J
    Kreichgauer, HP
    Kroemer, HK
    Eichelbaum, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R463 - R463
  • [10] Clinical Implications of P-Glycoprotein Modulation in Drug–Drug Interactions
    Marie Lund
    Tonny Studsgaard Petersen
    Kim Peder Dalhoff
    Drugs, 2017, 77 : 859 - 883
12345